Steven A. Kriegsman, Director at RXI PHARMACEUTICALS CORP (RXII), sold 7,200 shares at $4.90 ($35K) on 2009-04-30, disclosed to the SEC on 2009-05-01.
Scheduled sale ($35k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.54 | 1,700 | $8K | 22.3% |
| 2 | $4.90 | 5,500 | $27K | 77.7% |
| Total | $4.82 avg | 7,200 | $35K | 100% |
| Filing → |
| CYTR | BUY | 2012-02-24 | $51K | — | Filing → |
| RXII | SELL | 2009-08-20 | $28K | — | Filing → |
| RXII | SELL | 2009-07-06 | $13K | — | Filing → |